Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
Clinical trial NCT02443298 · COMPLETED
Trial details
- NCT number
- NCT02443298
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-23
- Primary completion
- 2017-10-13
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.